THE NEED FOR A COLD CHAIN FOR DEVELOPING COUNTRIES VACCINES is a significant obstacle for healthcare initiatives. It also contributes about 80% of the cost. Remember that Next Generation DNA VACCINES do not require a cold chain, and can be delivered nasally, making delivery significantly less challenging.